GPI-AP: Unraveling a New Class of Malignancy Mediators and Potential Immunotherapy Targets

With millions of cases diagnosed annually and high economic burden to cover expensive costs, cancer is one of the most difficult diseases to treat due to late diagnosis and severe adverse effects from conventional therapy. This creates an urgent need to find new targets for early diagnosis and thera...

Descripción completa

Detalles Bibliográficos
Autores principales: Hussein, Nada H., Amin, Nada S., El Tayebi, Hend M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7746843/
https://www.ncbi.nlm.nih.gov/pubmed/33344222
http://dx.doi.org/10.3389/fonc.2020.537311

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7746843/
https://www.ncbi.nlm.nih.gov/pubmed/33344222
http://dx.doi.org/10.3389/fonc.2020.537311

Ejemplares similares